Literature DB >> 19149553

African non human primates infected by SIV - why don't they get sick? Lessons from studies on the early phase of non-pathogenic SIV infection.

Anne-Sophie Liovat1, Béatrice Jacquelin, Mickaël J Ploquin, Françoise Barré-Sinoussi, Michaela C Müller-Trutwin.   

Abstract

African non human primates are natural hosts of SIV. The infection is generally non-pathogenic despite high steady-state levels of plasma viral RNA that in HIV-1 and SIVmac infections are associated with progression towards AIDS. The viral loads in the gut also are as high as in pathogenic HIV-1/SIVmac infections; but replication levels are lower in peripheral lymph nodes of chronically infected African green monkeys. There is a transient loss of CD4(+) T cells in the blood in SIVagm and SIVsm infections and an early dramatic and more persistent decrease in the gut. Although SIV in natural hosts is thus cytopathic, the continuous viral replication is not associated with immunopathology. T CD4(+) cells in blood, lymph nodes and gut manifest no or little increase of cell-death by apoptosis. The lymph node and gut architecture is not disrupted. The most striking difference between non-pathogenic SIV and pathogenic HIV-1/SIVmac infections is the lack of chronic T cell activation. Several studies are currently in progress to determine which factors are involved in the maintenance of the low activation level in the non-pathogenic SIV infections. There are two ways in which this could be achieved: (i) a lack of immune activation induction or (ii) an active downregulation of the immune activation. The arguments in favor of each of these two possible ways of immune activation control will be discussed in view of the most recent data in the literature. A particular focus is put on data on the innate immune system and the timing of induction of immunosuppressive mediators during the early phase of SIV infection.

Entities:  

Mesh:

Year:  2009        PMID: 19149553     DOI: 10.2174/157016209787048546

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  18 in total

1.  Minocycline attenuates HIV-1 infection and suppresses chronic immune activation in humanized NOD/LtsZ-scidIL-2Rγ(null) mice.

Authors:  Maneesh Singh; Pratibha Singh; Dolores Vaira; Mathieu Amand; Souad Rahmouni; Michel Moutschen
Journal:  Immunology       Date:  2014-08       Impact factor: 7.397

Review 2.  Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?

Authors:  A Saez-Cirion; B Jacquelin; F Barré-Sinoussi; M Müller-Trutwin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-05-12       Impact factor: 6.237

Review 3.  Systems biology of natural simian immunodeficiency virus infections.

Authors:  Steven E Bosinger; Béatrice Jacquelin; Arndt Benecke; Guido Silvestri; Michaela Müller-Trutwin
Journal:  Curr Opin HIV AIDS       Date:  2012-01       Impact factor: 4.283

4.  Short communication: HIV+ viremic slow progressors maintain low regulatory T cell numbers in rectal mucosa but exhibit high T cell activation.

Authors:  Julia M Shaw; Peter W Hunt; J William Critchfield; Delandy H McConnell; Juan Carlos Garcia; Richard B Pollard; Ma Somsouk; Steven G Deeks; Barbara L Shacklett
Journal:  AIDS Res Hum Retroviruses       Date:  2012-10-16       Impact factor: 2.205

Review 5.  Dissecting the role of dendritic cells in simian immunodeficiency virus infection and AIDS.

Authors:  Elizabeth R Wonderlich; Muhamuda Kader; Viskam Wijewardana; Simon M Barratt-Boyes
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

6.  Transient increase of interferon-stimulated genes and no clinical benefit by chloroquine treatment during acute simian immunodeficiency virus infection of macaques.

Authors:  Monica Vaccari; Claudio Fenizia; Zhong-Min Ma; Anna Hryniewicz; Adriano Boasso; Melvin N Doster; Christopher J Miller; Niklas Lindegardh; Joel Tarning; Alan L Landay; Gene M Shearer; Genoveffa Franchini
Journal:  AIDS Res Hum Retroviruses       Date:  2013-12-24       Impact factor: 2.205

7.  High content cellular immune profiling reveals differences between rhesus monkeys and men.

Authors:  Isabelle Magalhaes; Nalini K Vudattu; Raija K Ahmed; Sharon Kühlmann-Berenzon; Yen Ngo; Donata R Sizemore; Lena Wehlin; Frank Weichold; Jan Andersson; Yasir A W Skeiky; Jerry Sadoff; Hans Gaines; Rigmor Thorstensson; Mats Spångberg; Markus J Maeurer
Journal:  Immunology       Date:  2010-05-10       Impact factor: 7.397

8.  Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response.

Authors:  Béatrice Jacquelin; Véronique Mayau; Brice Targat; Anne-Sophie Liovat; Désirée Kunkel; Gaël Petitjean; Marie-Agnès Dillies; Pierre Roques; Cécile Butor; Guido Silvestri; Luis D Giavedoni; Pierre Lebon; Françoise Barré-Sinoussi; Arndt Benecke; Michaela C Müller-Trutwin
Journal:  J Clin Invest       Date:  2009-12       Impact factor: 14.808

Review 9.  HIV-associated chronic immune activation.

Authors:  Mirko Paiardini; Michaela Müller-Trutwin
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

10.  Inhibition of adaptive immune responses leads to a fatal clinical outcome in SIV-infected pigtailed macaques but not vervet African green monkeys.

Authors:  Jörn E Schmitz; Roland C Zahn; Charles R Brown; Melisa D Rett; Ming Li; Haili Tang; Sarah Pryputniewicz; Russell A Byrum; Amitinder Kaur; David C Montefiori; Jonathan S Allan; Simoy Goldstein; Vanessa M Hirsch
Journal:  PLoS Pathog       Date:  2009-12-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.